6-Year Data on IDEAL IMPLANT Presented at the Annual Meeting of the American Society of Plastic Surgery in Orlando, FL

ORLANDO, Fla., Oct. 6, 2017 /PRNewswire/ -- Ideal Implant Incorporated today announced that new 6-year clinical trial data on the IDEAL IMPLANT^® Structured Breast Implant will be included in two presentations at Plastic Surgery: The Meeting, the upcoming annual meeting of the American Society of Plastic Surgeons (ASPS).

Presentation Title: "6-Year Clinical Trial Results with the Structured Breast Implant"
Presenter: Gregg Anigian, MD
Date: Sunday, October 8, 2017
Time: 4:20 PM
Location: Orange County Convention Center, S320 EF

Presentation Title: "Choosing the Right Breast Implant Technology"  
Presenter: Robert S Hamas, MD
Date: Sunday, October 8, 2017
Time: 5:00 PM
Location: Orange County Convention Center, S310 A-D

IDEAL IMPLANT's six-year clinical trial data will be presented by Gregg Anigian, MD, a board-certified plastic surgeon with a practice in Dallas, TX. Dr. Anigian's presentation will show that of the 438 women who came in for six-year follow-up examinations, patient and surgeon satisfaction was 90% to 94%. The data also shows that, through 6 years, the IDEAL IMPLANT has a low risk of rupture (1.8%) and a low risk of Baker 3 & 4 capsule contrature (5.7%).

Robert S. Hamas, MD, plastic surgeon and inventor of the IDEAL IMPLANT, will also be presenting at the ASPS Annual Meeting in a panel titled "Choosing the Right Implant for the Right Situation." Dr. Hamas' presentation will highlight IDEAL IMPLANT's 6 year clinical data, advanced technology, and its advantages over other implants on the market.

About Ideal Implant
Ideal Implant Incorporated was founded in 2006 to develop, manufacture and market a new, third type of breast implant, the IDEAL IMPLANT^® Structured Breast Implant, which has advantages over both saline and silicone gel type implants. Its unique internal structure gives it a natural feel with only saline inside for safety and peace of mind. It contains no silicone gel, eliminating the risk of silent rupture. The company received FDA and Health Canada approval in 2014. The IDEAL IMPLANT is manufactured in the U.S. and is available through a Network of board certified and board-eligible plastic surgeons. Additional information may be obtained at www.idealimplant.com.

Refer to the FDA-approved IDEAL IMPLANT Patient Information Booklet at www.idealimplant.com for information about the risks and benefits associated with the IDEAL IMPLANT^® Structured Breast Implant.

SOURCE Ideal Implant Incorporated